CONTINUE TO ADMINISTER REMAINING SUPPLIES OF NIRSEVIMAB TO INFANTS AND TODDLERS.
For protection through the end of the RSV season, CDC recommends administration of remaining supplies of nirsevimab for eligible infant and toddlers through March; use of nirsevimab is summarized in this infographic.
CONTINUE YEAR-ROUND TO ADMINISTER PRIVATE-PURCHASE SUPPLIES OF RSV VACCINES TO ADULTS AGED 60 YEARS AND OLDER.
RSV vaccines appear to protect adults 60 years and older for at least 2 years, so continue to immunize them throughout the year.
In contrast, CDC recommends RSV vaccine to pregnant persons through the end of January. The benefits and cost-effectiveness of prenatal immunization against RSV are expected to diminish in most of the US during February and later months. Check with insurers regarding reimbursement for any administration after January.
DO NOT DISCARD UNUSED DOSES OF NIRSEVIMAB AND RSV VACCINES!
RSV vaccines and nirsevimab are expensive and have a lengthy shelf life, so unused doses can be saved for use this Fall! We encourage you to label remaining doses “Keep for Fall 2024.”
Unexpired VFC doses cannot be returned to McKesson.
Thanks for your work under challenging circumstances to protect Californians against RSV!
For more information, check out the EZIZ RSV FAQs page.
